NOTE: This article is more than five years old, but may still be relevant. For more recent content, see our news and blogs page.
Scientists William C Campbell and Satoshi Omura have been awarded the Nobel prize for medicine for their discovery of a way to treat river blindness.
Campbell and Omura together discovered a group of compounds known as avermectins, the derivatives of which are used to treat and prevent river blindness. Their research led to the creation of ivermectin (brand name Mectizan®) which is used to treat the disease in developing countries.
Sightsavers CEO Dr Caroline Harper said: “This is such exciting news and so well deserved. The drug these scientists discovered is used now to treat a number of neglected tropical diseases and we are close to eliminating several of them. Thanks to them, and to [pharmaceutical company] Merck, which provides Mectizan® free of charge, we have the capability to protect the billion people in the world who are at risk.
“Over the next five to ten years, if we have the funding, we should be able to rid the world of river blindness and lymphatic filariasis. We at Sightsavers have been working on these programmes for many years, and are so pleased that the Nobel prize committee has recognised how important they are.”
The Injaz fellowship will support Martins Imhansoloeva's research and PhD project on river blindness, a common infectious cause of sight loss.
Sightsavers’ Khadijah Bello travelled across north-central Nigeria to see how our programmes are fast-tracking the elimination of neglected tropical diseases.
The funding pledge is a huge step towards eliminating the diseases.
© 2025 Sightsavers. Registered charity number 20053246
Sightsavers want to give you a great experience on our website, tell as many people about our work as possible, and help change the lives of as many people as we can.